Experience

OCT is a leading CRO operating in Russia, Central and Eastern Europe and the US. With the team of more than 90 professionals, OCT provides a full range of high-quality services within Phase I to IV including the organization and conduct of BE studies.

With local expertise in the countries of our operations and a focus on quality, we ensure that the Sponsor’s product advances through clinical development and approval on time and within budget. Our experienced team delivers quality results for our clients' development needs from standalone CRO services such as medical writing, consultancy, project management/monitoring, data management / statistics to the management and conduct of full clinical programs.

Since 2005 OCT has been involved in more than 150 full-service and functional service projects in a number of therapeutic areas.

Please see below a breakdown of OCT’s experience by year, therapeutic area and phase:

Back pain
Therapeutic area:  Neurology
Phase:  III
Year:  2018

Functional dyspepsia
Therapeutic area:  Gastroenterology
Phase:  III
Year:  2018

Flue vaccine
Therapeutic area:  Infectious diseases
Phase:  n/a
Year:  2018

Ischemic heart disease
Therapeutic area:  Cardiology
Phase:  n/a
Year:  2018

Acute hemorrhoid
Therapeutic area:  Gastroenterology
Phase:  III
Year:  2018

Acute hemorrhoid
Therapeutic area:  Gastroenterology
Phase:  III
Year:  2018

Non-small-cell lung carcinoma
Therapeutic area:  Oncology
Phase:  I
Year:  2018

Pain
Therapeutic area:  Neurology
Phase:  I
Year:  2018

Ocular diseases
Therapeutic area:  Ophthalmology
Phase:  n/a
Year:  2018

Tuberculosis
Therapeutic area:  Infectious diseases
Phase:  I
Year:  2018

Ulcerative colitis
Therapeutic area:  Gastroenterology
Phase:  III
Year:  2018

Moderate to Severe Glabellar Lines
Therapeutic area:  Dermatology
Phase:  III
Year:  2018

Glaucoma
Therapeutic area:  Ophthalmology
Phase:  III
Year:  2018

Astenospermia
Therapeutic area:  Urology
Phase:  III
Year:  2017

Sexual Dysfunction
Therapeutic area:  Gynecology / Psychiatry
Phase:  III
Year:  2017

Acute posthemorrhagic anemia
Therapeutic area:  Surgery
Phase:  II
Year:  2017

Tuberculosis
Therapeutic area:  Infectious diseases
Phase:  BE study
Year:  2017

Rheumatoid Arthritis
Therapeutic area:  Rheumatology
Phase:  III
Year:  2017

Potassium deficiency
Therapeutic area:  Endocrinology
Phase:  n/a
Year:  2017

Osteoarthritis
Therapeutic area:  Rheumatology
Phase:  III
Year:  2017


Новости 1 - 20 of 273

Detailed study list see below: